Modulator role of infliximab and methotrexate through the transient receptor potential melastatin 2 (TRPM2) channel in neutrophils of patients with rheumatoid arthritis: a pilot study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.